Keio Innovation Initiative
Tokyo, Tokyokeio-innovation.co.jp
Overview
Keio Innovation Initiative (KII) is a venture capital firm jointly established by Keio University and Nomura Holdings. The firm focuses on investing in start-ups utilizing research outcomes and technologies developed at Keio University. It invests in IT and healthcare sectors including digital health, bioinformatics, and regenerative medicine. KII mainly invests the seed/early stage startups which originated from the university's research results, and provides hands-on support.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Starlight Engine株式会社 | Jul 2026 | First External Funding Round | Co-investor |
| Neusignal Therapeutics, Inc. | Jun 2026 | Series B | Co-investor |
| Graphenory | Apr 2026 | Seed | Co-investor |
| MiRESSO Co., Ltd. | Feb 2026 | Series A | Co-investor |
| Metagen Therapeutics, Inc. | Feb 2026 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
